HORMONE RECEPTOR NEGATIVE HER2 POSITIVE BREAST CANCER

HORMONE RECEPTOR NEGATIVE HER2 POSITIVE BREAST CANCER was reported 11 times

HORMONE RECEPTOR NEGATIVE HER2 POSITIVE BREAST CANCER is most prevalent among patients taking these drug classes:

# Drug class Count Frequency
0 Endoglycosidase [EPC] 1 0.0005
1 Estrogen Receptor Antagonist [EPC] 2 0.0000
2 HER2/neu Receptor Antagonist [EPC] 3 0.0000
3 Aromatase Inhibitor [EPC] 1 0.0000
4 GLP-1 Receptor Agonist [EPC] 2 0.0000
5 Alkylating Drug [EPC] 1 0.0000
6 Nucleoside Metabolic Inhibitor [EPC] 1 0.0000
7 Kinase Inhibitor [EPC] 2 0.0000